Auxeris Therapeutics Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Auxeris Therapeutics Inc.
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups feature companies developing Drugs that Promote Bone Growth, Breast Biopsy Technologies and Cardiovascular Drugs. Plus these selected Start-Ups across Health Care: BioSeek Inc., CombinatoRx Inc. and Cyberkinetics Inc.
Auxeris Therapeutics is using the cytokine RANK and its ligand as a drug target to identify anabolic bone-growth compounds.
Inspired by the commercializing of Lilly's osteoporosis drug, Forteo, start-ups are developing new classes of anabolic bone-forming agents around known and novel drug targets.
In Vivo briefly summarizes the technologies of these recently founded companies: Anacor Pharmaceuticals Inc., Auxeris Therapeutics Inc., Chimerix Inc., Ercole BioTech Inc., iThemba Pharmaceuticals (Pty) Ltd. and Trinity Biosystems Inc.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.